Next-Generation Solutions for Drug Discovery
is a start-up project at the Technische Universität Dresden (TUD) under developmental funding from the German Federal Ministry for Economic Affairs and Energy’s (BMWi) EXIST Forschungstransfer program. This two-year funding period provides time and support for moving our technologies from the research laboratory to full industrial deployment.
Our mission is to bring next-generation DNA-Encoded Chemical Library (DECL) technologies to the market. By further developing our technologies, DyNAbind is in position to boost drug discovery by increasing hit reliability as well as cost and time efficiency.
We’re interested in finding collaboration partners for our technology development. We invite groups of all sizes to investigate our technologies and potential services to see how DyNAbind’s next-generation DECL technologies can benefit your research or workflow. Please feel free to contact us for further discussion!
Hosting and Support